Sep 18 (IANS) India on Sunday reported 5,664 fresh Covid cases in the last 24 hrs, against 5,747 Covid cases reported on previous day, said the Union Health Ministry.
In the same period, the country has recorded 35 more Covid related deaths, taking the national fatalities tally to 5,28,337 as per the report.
Meanwhile, the active caseload of the country has marginally risen to 47,922 cases, accounting for 0.11 per cent of the country’s total positive cases.
The recovery of 4,555 patients in the last 24 hours took the cumulative tally to 4,39,57,929. Consequently, India’s recovery rate stands at 98.71 per cent.
Vaccine
Meanwhile, India’s Daily Positivity Rate has been reported to be 1.96 per cent, while the Weekly Positivity Rate in the country currently also stands at 1.79 per cent.
Also in the same period, a total of 2,89,228 tests were conducted across the country, increasing the overall tally to over 89.15 crore.
As of Sunday morning, India’s Covid-19 vaccination coverage exceeded 216.56 crore.
Over 4.08 crore adolescents have been administered the first dose of Covid-19 jab since the beginning of vaccination drive for this age bracket.
Starting twice daily flushing of the mucus-lined nasal cavity with a mild saline solution soon after testing positive for COVID-19 can significantly reduce hospitalization and death, investigators report.
They say the technique that can be used at home by mixing a half teaspoon each of salt and baking soda in a cup of boiled or distilled water then putting it into a sinus rinse bottle is a safe, effective and inexpensive way to reduce the risk of severe illness and death from coronavirus infection that could have a vital public health impact.
“What we say in the emergency room and surgery is the solution to pollution is dilution,” says Dr. Amy Baxter, emergency medicine physician at the Medical College of Georgia at Augusta University
“By giving extra hydration to your sinuses, it makes them function better.
If you have a contaminant, the more you flush it out, the better you are able to get rid of dirt, viruses and anything else,” says Baxter.
“We found an 8.5-fold reduction in hospitalizations and no fatalities compared to our controls,” says senior author Dr. Richard Schwartz, chair of the MCG Department of Emergency Medicine. “Both of those are pretty significant endpoints.”
Drs. Richard Schwartz and Amy Baxter/Photo:Medical College of Georgia
The study appears to be the largest, prospective clinical trial of its kind and the older, high-risk population they studied — many of whom had preexisting conditions like obesity and hypertension — may benefit most from the easy, inexpensive practice, the investigators say.
They found that less than 1.3% of the 79 study subjects age 55 and older who enrolled within 24-hours of testing positive for COVID-19 between Sept. 24 and Dec. 21, 2020, experienced hospitalization. No one died.
Among the participants, who were treated at MCG and the AU Health System and followed for 28 days, one participant was admitted to the hospital and another went to the emergency room but was not admitted.
Schwartz says Baxter brought him the idea early in the pandemic and he liked that it was inexpensive, easy to use and could potentially impact millions at a time where, like other health care facilities, the Emergency Department of the AU Health System was starting to see a lot of SARS-CoV-2-positive patients.
They knew that the more virus that was present in your body, the worse the impact, Baxter says. “One of our thoughts was: If we can rinse out some of the virus within 24 hours of them testing positive, then maybe we can lower the severity of that whole trajectory,” she says, including reducing the likelihood the virus could get into the lungs, where it was doing permanent, often lethal damage to many.
Covid/commons.wikimedia.org
Additionally, the now-infamous spiky SARS-CoV-2 is known to attach to the ACE2 receptor, which is pervasive throughout the body and in abundance in locations like the nasal cavity, mouth and lungs. Drugs that interfere with the virus’ ability to attach to ACE2 have been pursued, and Baxter says the nasal irrigation with saline helps decrease the usual robust attachment. Saline appears to inhibit the virus’ ability to essentially make two cuts in itself, called furin cleavage, so it can better fit into an ACE2 receptor once it spots one.
Participants self-administered nasal irrigation using either povidone-iodine, that brown antiseptic that gets painted on your body before surgery, or sodium bicarbonate, or baking soda, which is often used as a cleanser, mixed with water that had the same salt concentration normally found in the body.
But their experience indicates the saline solution alone sufficed. “It’s really just the rinsing and the quantity that matter,” Baxter says.
The investigators also wanted to know any impact on symptom severity, like chills and loss of taste and smell. Twenty-three of the 29 participants who consistently irrigated twice daily had zero or one symptom at the end of two weeks compared to 14 of the 33 who were less diligent.
Those who completed nasal irrigation twice daily reported quicker resolution of symptoms regardless of which of two common antiseptics they were adding to the saline water.
Others have shown the nasal irrigation, also called lavage, can also be effective in reducing duration and severity of infection by a family of viruses that include the coronaviruses, which are also known to cause the common cold, as well as the influenza viruses, the investigators write. “SARS-CoV-2 infection was another perfect situation for it,” Baxter says.
In fact, nasal irrigation is something that has been done for millennia in Southeast Asia, and Baxter had noted lower death rates from COVID-19 in countries like Laos, Vietnam and Thailand. “Those were places that I knew from having been there where they use nasal irrigation as a normal part of hygiene just like brushing their teeth,” she says. A 2019 pre-COVID study provided evidence that regular nasal irrigation in Thailand can improve nasal congestion, decrease postnasal drip, improve sinus pain or headache, improve taste and smell and improve sleep quality.
Saline water
Schwartz said the simplicity and safety of the treatment had him recommending nasal irrigation to positive patients early on and the published results make him even more confident in recommending nasal irrigation to essentially anyone who tests positive.
“Many of the people who have been using this now for months have told me their seasonal allergies have gone away, that it really makes a huge difference in any of the things that go through the nose that are annoying.”
A study released in September 2020 indicated that gargling with a saline-based solution can reduce viral load in COVID-19, and another released in 2021 suggested that saline works multiple ways to reduce cold symptoms related to infection with other coronaviruses and might work as well as a first-line intervention for COVID-19.
Despite the two nostrils, the nasal sinus is just one cavity, so the water is pushed into one side and comes out the other, Baxter notes.
After the stress of the COVID-19 pandemic, many Americans are now investing in themselves through cosmetic procedures, despite an uncertain economy.
The American Society of Plastic Surgeons (ASPS) polled member surgeons nationwide and found more than three-quarters of cosmetic-focused plastic surgery practices are seeing more business than before the pandemic, with nearly 30 percent reporting their business has at least doubled.
“With COVID, we prepared for the worst. But when we were able to reopen our office, we were pleasantly surprised with the incredible surge of demand for our cosmetic services, both surgical and noninvasive,” said Bob Basu, a board-certified plastic surgeon in Houston and board vice president of finance of the American Society of Plastic Surgeons. “I initially thought that we would see some of that demand drop off, and that’s not been the case. We’re actually still seeing very high demand.”
Covid/commons.wikimedia.org
Basu says there are a variety of reasons behind the increased demand. For many patients, COVID shutdowns and the ability to work from home gave them the time they needed to heal, without disrupting their normal busy routine. Others say the money saved on things like travel and dining out during the pandemic allowed them to invest in themselves.
“COVID changed everything. No one was traveling, vacations got canceled. So I think a lot of families and patients had a lot more disposable income. And so, they found that this is the right time for them to do a cosmetic plastic surgery procedure,” Basu said.
The survey also found that women between the ages of 31 and 45 were by far the most likely to request popular procedures such as breast augmentations, liposuction and tummy tucks. Basu says millennials are not only savvy about their options, but are also more open about their choice to seek plastic surgery than older generations.
tattoo/en.wikipedia.org
“Millennials are very sophisticated in terms of getting the information they want. They share their experiences with other people through social media platforms or other methods. And so, these procedures are no longer taboo — They’re actually relatable and accessible,” Basu said. “Because of this open sharing, patients also come in well-versed about the procedures of interest. And so it really allows us to have a really productive discussion about their options.”
Megan Gilbert, 35, was one of those millennials who did her research. When the pandemic halted her young family’s busy lifestyle, they used the opportunity to focus on their health. But after a twenty-five-pound weight loss, Gilbert still had some insecurities when looking in the mirror.
A friend referred Gilbert to Dr. Basu, who worked with her to find the right size and type of breast implant. At the same time as her breast augmentation, he performed a breast lift to give her the look and shape she desired.
Tattoo/Tattoo inks/commons.wikimedia.org
“I couldn’t be happier with the results. Having that confidence back and feeling better about myself resonates in every part of my life, including with my family,” Gilbert said. “I want my kids to be happy and secure in their life and in who they are, and if they don’t see that in me, it’s hard for them to see it in themselves.”
Although the surge in cosmetic procedures may be driven by women under 45, Basu says he’s seeing more patients across every age group and gender who are interested in procedures to help them look and feel their best.
The survey found that over 40 percent of plastic surgeons are reporting longer wait times between consultation and surgery than before the pandemic, so experts encourage anyone considering a cosmetic procedure to plan ahead as much as possible.
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure,according to research presented at ESC Congress 2022.1 The study also found that the vaccines were not associated with an increased risk of worsening heart failure, venous thromboembolism or myocarditis in heart failure patients.
“Our results indicate that heart failure patients should be prioritised for COVID-19 vaccinations and boosters,” said study author Dr. Caroline Sindet-Pedersen of Herlev and Gentofe Hospital, Hellerup, Denmark. “COVID-19 vaccines will continue to be important for preventing morbidity and mortality in vulnerable patient populations. Thus, studies emphasising the safety of these vaccines are essential to reassure those who might be hesitant and ensure continued uptake of vaccinations.”
Patients with heart failure are at increased risk of hospitalisation, need for mechanical ventilation, and death due to COVID-19.2 Vaccination reduces the risk of serious illness from COVID-19. However, “Due to perceptions about possible cardiovascular side effects from mRNA vaccines in heart failure patients, this study examined the risk of cardiovascular complications and death associated with mRNA vaccines in a nationwide cohort of patients with heart failure,” said Dr. Sindet-Pedersen.
The study included 50,893 unvaccinated patients with heart failure in 2019 and 50,893 patients with heart failure in 2021 who were vaccinated with either of the two mRNA vaccines (BNT162B2 or mRNA-1273).3 The two groups were matched for age, sex, and duration of heart failure. The median age of participants was 74 years and 35% were women. The median duration of heart failure was 4.1 years. Participants were followed for 90 days for all-cause mortality, worsening heart failure, venous thromboembolism, and myocarditis, starting from the date of the second vaccination for the 2021 group and the same date in 2019 for the unvaccinated group.
The researchers compared the risk of adverse outcomes in the two groups, after standardising for age, sex, heart failure duration, use of heart failure medications, ischaemic heart disease, cancer, diabetes, atrial fibrillation, and admission with heart failure less than 90 days before the first date of follow up. Dr. Sindet-Pedersen explained: “Standardisation imitates a randomised trial and is a way to obtain a better causal interpretation of the results from observational studies.”
Among 101,786 heart failure patients, the researchers found that receiving an mRNA vaccine was not associated with an increased risk of worsening heart failure, myocarditis or venous thromboembolism but was associated with a decreased risk of all-cause mortality. The standardised risk of all-cause mortality within 90 days was 2.2% in the 2021 cohort (vaccinated) and 2.6% in the 2019 cohort (not vaccinated), showing a significantly lower risk for all-cause mortality in 2021 versus 2019. The standardised risk of worsening heart failure within 90 days was 1.1% in both cohorts. Similarly, no significant differences were found between groups for venous thromboembolism or myocarditis.
Dr. Sindet-Pedersen concluded: “The study suggests that there should be no concern about cardiovascular side effects from mRNA vaccines in heart failure patients. In addition, the results point to a beneficial effect of vaccination on mortality.”